Effective Cancer Targeting Using an Anti-tumor Tissue Vascular Endotheliumm specific Monoclonal Antibody (TES-23)

Search this Article

Author(s)

    • WAKAI Yukiko
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • MATSUI Junji
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • KOIZUMI Keiichi
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • TSUNODA Shin-ichi
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • MAKIMOTO Hiroo
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • OHIZUMI Iwao
    • Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
    • TANIGUCHI Kenji
    • Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
    • KAIHO Shin-ichi
    • Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
    • SAITO Hiroyuki
    • Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
    • UTOGUCHI Naoki
    • Showa College of Pharmaceutical Sciences, 3-3165 Higashi Tamagawa Gakuen
    • TSUTSUMI Yasuo
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • NAKAGAWA Shinsaku
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
    • OHSUGI Yoshiyuki
    • Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
    • MAYUMI Tadanori
    • Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University

Journal

  • Jpn. J. Cancer Res.

    Jpn. J. Cancer Res. 91(12), 1319-1325, 2000-12-30

References:  25

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008060292
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09105050
  • Data Source
    CJP  CJPref 
Page Top